Next Article in Journal
Cyclic Peptides in Pipeline: What Future for These Great Molecules?
Previous Article in Journal
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
Previous Article in Special Issue
RadioLigand Therapy with [177Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France
 
 
Review

Article Versions Notes

Pharmaceuticals 2023, 16(7), 995; https://doi.org/10.3390/ph16070995
Action Date Notes Link
article xml file uploaded 12 July 2023 11:28 CEST Original file -
article xml uploaded. 12 July 2023 11:28 CEST Update https://www.mdpi.com/1424-8247/16/7/995/xml
article pdf uploaded. 12 July 2023 11:28 CEST Version of Record https://www.mdpi.com/1424-8247/16/7/995/pdf
article html file updated 12 July 2023 11:29 CEST Original file -
article html file updated 20 July 2023 21:53 CEST Update https://www.mdpi.com/1424-8247/16/7/995/html
Back to TopTop